Senior Associate

Rose Kesselman, MPH

Rose is a healthcare policy professional with expertise in pharmaceutical pricing, coverage, and reimbursement across Medicare, Medicaid, and commercial payers. At ADVI Health, she supports clients in navigating federal and state policy developments, with a focus on pharmaceuticals, biologics, and cell and gene therapies.

Before joining ADVI, Rose was a senior associate at Berkeley Research Group, where she advised on healthcare transactions, analyzed policy impacts, and developed client-facing publications. She has also worked with Elevance Health’s Government and State Affairs team, tracking state and federal healthcare legislation, and with Soapy Care in Tel Aviv, where she researched and promoted global public health initiatives.

Rose holds both a Bachelor of Science in Public Health and Master of Public Health (MPH) in Health Policy from the George Washington University Milken Institute School of Public Health.

CEO insights

Real analysis from people who’ve been there

Cell and Gene

Delivering on CAR T-cell Therapy’s Promise: Policy Solutions for the Next Era of Cancer Care

CAR T-cell therapy offers a groundbreaking treatment option for patients with relapsed or refractory hematologic malignancies, yet access remains severely …

Alicia Silver, MPP
November 21, 2025

Reach out

Own your edge

We don’t just guide the market. We shape it. Map your market access moves with #ADVIIntelligence. Proven advantage. Unmatched partnership.